Randomized, Double-blind Placebo Controlled Trial With Topiramate for the Treatment of Obese Patients With Binge Eating Disorder.

Trial Profile

Randomized, Double-blind Placebo Controlled Trial With Topiramate for the Treatment of Obese Patients With Binge Eating Disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jan 2011

At a glance

  • Drugs Topiramate (Primary)
  • Indications Binge-Eating Disorder
  • Focus Therapeutic Use
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 23 Oct 2007 The expected completion date for this trial is now 1 Apr 2005.
    • 22 Oct 2007 Status changed from in progress to completed.
    • 24 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top